Companies House true 2023-08-01 2024-07-31 false 06010833 uk-bus:Director1 2023-08-01 2024-07-31 06010833 uk-bus:Director2 2023-08-01 2024-07-31 06010833 2023-08-01 2024-07-31 06010833 2024-07-31 06010833 uk-bus:EntityHasNeverTraded 2023-08-01 2024-07-31 06010833 uk-bus:FRS102 2023-08-01 2024-07-31 06010833 uk-bus:FullAccounts 2023-08-01 2024-07-31 06010833 uk-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 06010833 2023-07-31 06010833 uk-bus:OrdinaryShareClass1 2023-08-01 2024-07-31 06010833 uk-bus:OrdinaryShareClass2 2023-08-01 2024-07-31 06010833 uk-bus:OrdinaryShareClass3 2023-08-01 2024-07-31 06010833 uk-bus:PreferenceShareClass1 2023-08-01 2024-07-31 06010833 uk-bus:PreferenceShareClass2 2023-08-01 2024-07-31 06010833 uk-bus:PreferenceShareClass3 2023-08-01 2024-07-31 06010833 uk-core:ShareCapitalPreferenceShares 2024-07-31 06010833 uk-core:ShareCapitalPreferenceShares 2023-07-31 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 06010833

SHERIDAN PHARMACY LIMITED

Dormant Accounts

31 July 2024

SHERIDAN PHARMACY LIMITED Registered Number 06010833

Balance Sheet as at 31 July 2024

2024 2023
£ £
Called up share capital not paid
158000
158000
Net assets
158000
158000
Issued share capital
158000 Ordinary Shares of £ 1 each 158000 158000
Total Shareholder funds
158000
158000

STATEMENTS

  1. For the year ending 31 July 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 25 April 2025

And signed on their behalf by:
Muhammad Irfan Motala, Director